文献速递血栓与止血

免疫性血小板减少症诊断临床预测模型的开发与内部验证

Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2022-10-14

研究基于McMaster ITP注册库中523例血小板减少患者数据,用惩罚逻辑回归构建Predict-ITP Tool,用于初次血液科会诊时预测免疫性血小板减少症(ITP)诊断概率。最终模型纳入血小板计数变异性、最低血小板计数、最大平均血小板体积和大出血史四个变量,内部验证显示乐观校正c统计量为0.83,校准斜率为0.88。

要点

  • Predict-ITP Tool可在初次血液科会诊时估算血小板减少患者ITP诊断的可能性。
  • 模型纳入血小板计数变异性、最低血小板计数、最大平均血小板体积和大出血史四个变量。
  • 内部验证乐观校正c统计量为0.83,校准斜率为0.88,区分度与校准良好。

核心结论

  • Predict-ITP Tool可在初次血液科会诊时估算给定血小板减少患者患ITP的可能性。
  • 该工具对ITP诊断具有高预测准确性。

研究设计与样本

  • 基于McMaster ITP注册库中523例血小板减少患者的数据,使用惩罚逻辑回归构建ITP诊断临床预测模型(Predict-ITP Tool)。
  • ITP病例定义为血小板计数低于100 × 10^9/L且对高剂量皮质类固醇或静脉免疫球蛋白有血小板计数反应,反应定义为血小板计数高于50 × 10^9/L且至少为基线的两倍。
  • 内部验证采用bootstrap重抽样,通过c统计量评估模型区分度,通过校准斜率、校准-in-the-large和校准图评估校准度。

主要发现

  • 最终模型纳入以下变量:血小板计数变异性(基于三个或以上血小板计数值)、最低血小板计数值、最大平均血小板体积和大出血史(按ITP出血量表定义)。
  • 乐观校正c统计量为0.83,校准斜率为0.88,所有性能指标的校准-in-the-large均<0.001,标准误<0.001,表明区分度良好且校准极佳。

关键数值与推荐

  • ITP病例定义:血小板计数低于100 × 10^9/L,且对高剂量皮质类固醇或静脉免疫球蛋白有反应,反应定义为血小板计数高于50 × 10^9/L且至少为基线的两倍。
  • 最终模型纳入4个预测变量:血小板计数变异性(基于三个或以上血小板计数值)、最低血小板计数值、最大平均血小板体积、大出血史(按ITP出血量表定义)。
  • 乐观校正c统计量为0.83,校准斜率为0.88,校准-in-the-large均<0.001(标准误<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune thrombocytopenia (ITP) is a diagnosis of exclusion that can resemble other thrombocytopenic disorders. OBJECTIVES: To develop a clinical prediction model (CPM) for the diagnosis of ITP to aid hematogists in investigating patients presenting with undifferentiated thrombocytopenia. METHODS: We designed a CPM for ITP diagnosis at the time of the initial hematology consultation using penalized logistic regression based on data from patients with thrombocytopenia enrolled in the McMaster ITP registry (n = 523) called the Predict-ITP Tool. The case definition for ITP was a platelet count less than 100 × 109 /L and a platelet count response after high-dose corticosteroids or intravenous immune globulin, defined as the achievement of a platelet count above 50 × 109 /L and at least a doubling of baseline. Internal validation was done using bootstrap resampling. Model discrimination was assessed by the c-statistic, and calibration was assessed by the calibration slope, calibration-in-the-large, and calibration plot. RESULTS: The final model included the following variables: (1) platelet count variability (based on three or more platelet count values), (2) lowest platelet count value, (3) maximum mean platelet volume, and (4) history of major bleeding (defined by the ITP bleeding scale). The optimism-corrected c-statistic was 0.83, the calibration slope was 0.88, and calibration-in-the-large for all performance measures was <0.001 with standard error <0.001, indicating good discrimination and excellent calibration. CONCLUSIONS: The Predict-ITP Tool can estimate the likelihood of ITP for a given patient with thrombocytopenia at the time of the initial hematology consultation. The tool had high predictive accuracy for the diagnosis of ITP.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Li N, Mahamad S, Parpia S, et al. Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. J Thromb Haemost. 2022. PMID: 36121734. doi:10.1111/jth.15885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。